The medical technology industry is highly competitive and continues to evolve, with success measured by the development of innovative products and the value brought to stakeholders. We are committed to developing new technologies and providing innovative patient care, which reflects our organizational resilience in adapting to external pressures and market demands. In 2016, we invested 15.0% of our net sales in research and development, emphasizing our focus on innovation and operational flexibility to respond effectively to environmental disruptions. The approval of various products, including the advanced edwards intuity elite valve system and the inspiris resilia aortic valve, demonstrates our ability to transform and reconfigure our offerings in response to customer needs and market conditions. Our strategic initiatives, including the acquisition of valtech, highlight our commitment to resource generation and inter-organizational collaboration, which are essential for maintaining organizational health and resilience. The increase in net sales of transcatheter heart valve therapy products was driven by the successful launch of the edwards sapien 3 valve, showcasing our capacity for operational continuity and performance maintenance under challenging conditions. Furthermore, we have established mechanisms for risk assessment and management, enabling us to navigate complexities and uncertainties in the healthcare environment. Our focus on generating robust clinical, economic, and quality of life evidence is indicative of our future orientation and resilience strategies, aimed at encouraging the adoption of innovative medical therapies. The fluctuations in gross profit margins due to foreign currency exchange rates and product mix adjustments reflect the need for adaptability and strategic response to external disturbances. We recognize the importance of stakeholder engagement and collaboration networks in fostering organizational agility and effectiveness, particularly in times of adversity. Our financial position as of December 31, 2016, indicates sufficient liquidity to fund current operational requirements, demonstrating our resourcefulness and strategic foresight in managing financial resources. The ongoing evaluation of uncertain tax positions and the pursuit of advance pricing agreements illustrate our proactive measures in navigating regulatory complexities, which are critical for sustaining organizational resilience. Overall, our commitment to innovation, strategic adaptation, and effective resource management positions us to confront future challenges and maintain a trajectory of growth and flourishing in a turbulent market landscape.